TRIM25 controls the Androgen Receptor and PSA/KLK3 levels in Prostate Cancer
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
Karlsruhe, Karlsruher Institut für Technologie (KIT), Dissertation, 2023
- Schlagwort
-
Prostatakrebs
- Ereignis
-
Veröffentlichung
- (wo)
-
Karlsruhe
- (wer)
-
KIT-Bibliothek
- (wann)
-
2024
- Urheber
- Beteiligte Personen und Organisationen
-
Blattner, Christine
Cato, Andrew C.
- DOI
-
10.5445/IR/1000172055
- URN
-
urn:nbn:de:101:1-2407030458420.091918647018
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
25.03.2025, 13:52 MEZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Pauletto, Eleonora
- Blattner, Christine
- Cato, Andrew C.
- KIT-Bibliothek
Entstanden
- 2024
Ähnliche Objekte (12)
Androgen receptor expression in the clinically localized prostate cancer
PRK1/PKN1 controls migration and metastasis of androgen-independent prostate cancer cells
Docetaxel in the management of PSA progression following primary androgen deprivation for prostate cancer
Docetaxel in the management of PSA progression following primary androgen deprivation for prostate cancer
Androgen receptor‐mediated transcriptional repression targets cell plasticity in prostate cancer
Androgen receptor deregulation drives bromodomain-mediated chromatin alterations in prostate cancer
LSD1 controls metastasis of androgen-independent prostate cancer cells through PXN and LPAR6
Small molecule BAG1L inhibitors for the treatment of androgen receptor-dependent prostate cancer
Regulation of human androgen receptor by corepressors and signal transduction in prostate cancer
Prognostic significance of androgen receptor splice variant 7 and glucocorticoid receptor expression in high-risk prostate cancer
Three microRNAs synergistically repress androgen receptor signaling and are downregulated in prostate carcinoma
Analysis of regulation of angiogenesis by androgen receptor ligands in castration-resistant prostate cancer
Androgen receptor expression in the clinically localized prostate cancer
PRK1/PKN1 controls migration and metastasis of androgen-independent prostate cancer cells
Docetaxel in the management of PSA progression following primary androgen deprivation for prostate cancer
Docetaxel in the management of PSA progression following primary androgen deprivation for prostate cancer
Androgen receptor‐mediated transcriptional repression targets cell plasticity in prostate cancer
Androgen receptor deregulation drives bromodomain-mediated chromatin alterations in prostate cancer
LSD1 controls metastasis of androgen-independent prostate cancer cells through PXN and LPAR6
Small molecule BAG1L inhibitors for the treatment of androgen receptor-dependent prostate cancer
Regulation of human androgen receptor by corepressors and signal transduction in prostate cancer
Prognostic significance of androgen receptor splice variant 7 and glucocorticoid receptor expression in high-risk prostate cancer
Three microRNAs synergistically repress androgen receptor signaling and are downregulated in prostate carcinoma
Analysis of regulation of angiogenesis by androgen receptor ligands in castration-resistant prostate cancer
Androgen receptor expression in the clinically localized prostate cancer
PRK1/PKN1 controls migration and metastasis of androgen-independent prostate cancer cells
Docetaxel in the management of PSA progression following primary androgen deprivation for prostate cancer
Docetaxel in the management of PSA progression following primary androgen deprivation for prostate cancer
Androgen receptor‐mediated transcriptional repression targets cell plasticity in prostate cancer
Androgen receptor deregulation drives bromodomain-mediated chromatin alterations in prostate cancer
LSD1 controls metastasis of androgen-independent prostate cancer cells through PXN and LPAR6
Small molecule BAG1L inhibitors for the treatment of androgen receptor-dependent prostate cancer
Regulation of human androgen receptor by corepressors and signal transduction in prostate cancer
Prognostic significance of androgen receptor splice variant 7 and glucocorticoid receptor expression in high-risk prostate cancer
Three microRNAs synergistically repress androgen receptor signaling and are downregulated in prostate carcinoma